Fujian Wanchen Biotechnology Co. Ltd Capital Reinvestment Ratio
Fujian Wanchen Biotechnology Co. Ltd capital reinvestment ratio. Fujian Wanchen Biotechnology Co. Ltd (300972) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥3.63 Billion) in capital expenditures (CN¥77.44 Million). Check Fujian Wanchen Biotechnology Co. Ltd (300972) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Capital reinvestment ratio of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. This chart tracks Fujian Wanchen Biotechnology Co. Ltd's Capital Reinvestment Ratio across 7 annual periods. Also explore 300972 net assets growth trend to track the company's year-over-year net asset growth rate.
Fujian Wanchen Biotechnology Co. Ltd Capital Reinvestment Ratio by Year (2019–2025)
Fujian Wanchen Biotechnology Co. Ltd capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see 300972 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥3.63 Billion | CN¥77.44 Million | ▼ -84.5% |
| 2024 | 0.14x | CN¥848.35 Million | CN¥116.65 Million | ▼ -35.7% |
| 2023 | 0.21x | CN¥1.02 Billion | CN¥218.91 Million | ▼ -95.2% |
| 2022 | 4.49x | CN¥70.38 Million | CN¥316.34 Million | ▲ +968.4% |
| 2021 | 0.42x | CN¥98.82 Million | CN¥41.57 Million | ▲ +17.2% |
| 2020 | 0.36x | CN¥156.24 Million | CN¥56.10 Million | ▲ +60.2% |
| 2019 | 0.22x | CN¥177.28 Million | CN¥39.73 Million | — |